DOAC

EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 3m 40s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s

Minh That Ton , Tri Huynh Quang Ho , Viet Lan Nguyen , et al

Read time: 18m

Tri Huynh Quang Ho , Minh That Ton , Viet Lan Nguyen , et al

Read time: 18m
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s
ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib

Afzal Sohaib,

Watch time: 3m 29s
ESC 22: APOLLO: Apixaban for Prevention of Thromboembolic Outcomes in COVID

Renato D Lopes,

Watch time: 3m 57s
ESC 22: ACT: Anti-Coronavirus Therapies to Prevent Progression of COVID-19

Sanjit Jolly,

Watch time: 4m 59s
ESC 22: Milvexian in Addition to Aspirin ＆ Clopidogrel for Secondary Stroke

Mukul Sharma,

Watch time: 6m 26s
ESC 22: Dosing of Asundexian in Pts With Non-Cardioembolic Ischemic Stroke

Ashkan Shoamanesh,

Watch time: 7m 9s
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17m 13s
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24m 27s

Julia Sikorska , James Uprichard ,

Doreen Su-Yin Tan, Gheorghe-Andrei Dan, Oskars Kalējs, et al

Watch time: 1h 1m 55s

Daniel TT Chong , Felicita Andreotti , Peter Verhamme , et al

Read time: 15m

Sotiris Antoniou , Bernard Man Yung Cheung, Krzysztof Filipiak, et al

Watch time: 6h 2m 18s (6 videos)

Tri Huynh Quang Ho , Minh That Ton , Viet Lan Nguyen , et al

Read time: 18m
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24m 27s

Minh That Ton , Tri Huynh Quang Ho , Viet Lan Nguyen , et al

Read time: 18m

Antoni Martínez-Rubio , Mario DiazNuila-Alcazar , Anna Soria Cadena , et al

Antoni Martínez-Rubio , Gheorghe-Andrei Dan ,

ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17m 13s

Emmanuel Sorbets , Philippe Gabriel Steg ,

Carina Blomström-Lundqvist , Helmut Pürerfellner , Alex White , et al

Media

Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s

Ignacio Cruz, Jens Erik Nielsen Kudsk, Prof Henning Ebelt, et al

Watch time: 2h 5m 51s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s

Doreen Su-Yin Tan, Gheorghe-Andrei Dan, Oskars Kalējs, et al

Watch time: 1h 1m 55s

Pablo Avanzas, Román Freixa Pamias, Antoni Martínez-Rubio, et al

Watch time: 28m 4s
ESC 22: APOLLO: Apixaban for Prevention of Thromboembolic Outcomes in COVID

Renato D Lopes,

Watch time: 3m 57s
ESC 22: ACT: Anti-Coronavirus Therapies to Prevent Progression of COVID-19

Sanjit Jolly,

Watch time: 4m 59s

Sotiris Antoniou , Bernard Man Yung Cheung, Krzysztof Filipiak, et al

Watch time: 6h 2m 18s (6 videos)
Dual Antithrombotic Therapy With Dabigatran

Christopher P Cannon,

Watch time: 5m 44s
View from the Thoraxcenter - What's hot at ESC 2019

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 18m 17s
AHA 2019: Updates from GALILEO-4D

Ole De Backer,

Watch time: 4m 8s
ESC 2020: Edoxaban for Elderly AF Patients — Dr Ken Okumura

Ken Okumura,

Watch time: 8m 16s

Articles

Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?

Mahmoud Abdelnabi

,

Abdallah Almaghraby

,

Yehia Saleh

,

Published:

26 February 2020

Citation:

European Cardiology Review 2020;15:e06.

DOI:

https://doi.org/10.15420/ecr.2019.1.3
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 779
  • Downloads: Downloads 20
  • Citations: 4

DOACs in Chronic Coronary Syndromes

Emmanuel Sorbets

,

Philippe Gabriel Steg

,

Published:

26 February 2020

Citation:

European Cardiology Review 2020;15:e10.

DOI:

https://doi.org/10.15420/ecr.2018.24.2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1024
  • Downloads: Downloads 63
  • Citations: 2

AF in Cancer Patients: A Different Need for Anticoagulation?

Ana Pardo Sanz

,

Jose Luis Zamorano

,

Published:

30 April 2019

Citation:

European Cardiology Review 2019;14(1):65–7

DOI:

https://doi.org/10.15420/ecr.2018.32.2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 709
  • Downloads: Downloads 20
  • Citations: 13

Prospective and Centralized Follow-Up of a Territorial Protocol of Use of Direct Oral Anticoagulants in Non Valvular Atrial Fibrillation

Fernando Worner

,

Cristina Marzo

,

Kristian Rivera

,

Nuria Sans

,

Ainara Ferrero

,

Joan Antoni Schoenenberger

,

Leonardo Galván

,

Albina Aldomà

,

Citation:

European Cardiology Review 2017;12(2):108.

DOI:

https://doi.org/10.15420/ecr.2017:23:17
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 304
  • Downloads: Downloads 2